Oncogenic KRAS promotes malignant brain tumors in zebrafish

Por Ju, Bensheng, Chen, Wenbiao, Orr, Brent A, Spitsbergen, Jan M, Jia, Sujuan, Eden, Christopher J, Henson, Hannah E, Taylor, Michael R
Publicado no Mol Cancer (2015)

Organotypic brain explant culture as a drug evaluation system for malignant brain tumors

Por Minami, Noriaki, Maeda, Yusuke, Shibao, Shunsuke, Arima, Yoshimi, Ohka, Fumiharu, Kondo, Yutaka, Maruyama, Koji, Kusuhara, Masatoshi, Sasayama, Takashi, Kohmura, Eiji, Saya, Hideyuki, Sampetrean, Oltea
Publicado no Cancer Med (2017)

Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling

Por Cockle, Julia V., Rajani, Karishma, Zaidi, Shane, Kottke, Timothy, Thompson, Jill, Diaz, Rosa Maria, Shim, Kevin, Peterson, Tim, Parney, Ian F., Short, Susan, Selby, Peter, Ilett, Elizabeth, Melcher, Alan, Vile, Richard
Publicado no Neuro Oncol (2016)

Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis

Por Gril, Brunilde, Palmieri, Diane, Qian, Yong, Smart, DeeDee, Ileva, Lilia, Liewehr, David J., Steinberg, Seth M., Steeg, Patricia S.
Publicado em 2010

CMET-19. CLINICAL RISK ASSESSMENT SCORE TO ESTIMATE THE LIKELIHOOD OF PSEUDOPROGRESSION VERSUS TUMOR GROWTH FOLLOWING STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES

Por Skeie, Bente, Øyvind Enger, Per, Pedersen, Paal-Henning, Olve Skeie, Geir
Publicado no Neuro Oncol (2018)

LGG-08. A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY

Por Fangusaro, Jason, Onar-Thomas, Arzu, Poussaint, Tina Y, Wu, Shengjie, Ligon, Azra H, Lindeman, Neal, Banerjee, Anu, Packer, Roger J, Kilburn, Lindsay B, Pollack, Ian F, Jakacki, Regina I, Qaddoumi, Ibrahim, Fisher, Paul G, Dhall, Girish, Baxter, Patricia, Kreissman, Susan G, Stewart, Clinton F, Pfister, Stefan M, Jones, David TW, Vezina, Gilbert, Stern, Jessica, Panigrahy, Ashok, Jones, Blaise V, Patay, Zoltan, Tamrazi, Benita, Jones, Jeremy Y, Haque, Sofia S, Enterline, David S, Cha, Soonmee, Doyle, Laurence A, Smith, Malcolm, Boyett, James M, Dunkel, Ira J, Fouladi, Maryam
Publicado no Neuro Oncol (2017)

Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells

Por Shingu, Takashi, Holmes, Lindsay, Henry, Verlene, Wang, Qianghu, Latha, Khatri, Gururaj, Anupama E., Gibson, Laura A., Doucette, Tiffany, Lang, Frederick F., Rao, Ganesh, Yuan, Liang, Sulman, Erik P., Farrell, Nicholas P., Priebe, Waldemar, Hess, Kenneth R., Wang, Yaoqi A., Hu, Jian, Bögler, Oliver
Publicado no J Transl Med (2016)

The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site

Por Alonso-Camino, Vanesa, Rajani, Karishma, Kottke, Timothy, Rommelfanger-Konkol, Diana, Zaidi, Shane, Thompson, Jill, Pulido, Jose, Ilett, Elizabeth, Donnelly, Oliver, Selby, Peter, Pandha, Hardev, Melcher, Alan, Harrington, Kevin, Diaz, Rosa Maria, Vile, Richard
Publicado no Mol Ther (2014)

Pediatric low-grade glioma in the era of molecular diagnostics

Por Scott Ryall, Uri Tabori, Cynthia Hawkins
Publicado em 2020-03-01

TMOD-43. A PORCINE MODEL OF NEUROFIBROMATOSIS TYPE I-ASSOCIATED NERVOUS SYSTEM TUMORS

Por Isakson, Sara, Coutts, Alex, Largaespada, David, Watson, Adrienne
Publicado no Neuro Oncol (2017)

Demonstration of differential radiosensitivity based upon mutation profile in metastatic melanoma treated with stereotactic radiosurgery

Por Rutter, Charles E., Johung, Kimberly L., Yao, Xiaopan, Lu, Alex Y., Jilaveanu, Lucia B., Yu, James B., Contessa, Joseph N., Kluger, Harriet M., Chiang, Veronica L.S., Bindra, Ranjit S.
Publicado no J Radiosurg SBRT (2016)

Long-lasting stable disease with mTOR inhibitor treatment in a patient with a perivascular epithelioid cell tumor: A case report and literature review

Por Flechter, Ezequiel, Zohar, Yaniv, Guralnik, Ludmila, Passhak, Maria, Sela, Gil Bar
Publicado no Oncol Lett (2016)

RARE-31. DUAL BRAF/MEK THERAPY FOR PATIENTS WITH BRAF V600E-MUTATED TUMORS: DRAMATIC CLINICAL AND RADIOGRAPHIC RESPONSES AND A REDUCTION IN CUTANEOUS TOXICITY

Por Bernstein, Aaron, Mrowczynski, Oliver, Khalsa, Amrit, Ryan, Sandra, Chung, Catherine, Glantz, Michael
Publicado no Neuro Oncol (2017)

Recombinant Interleukin-1 Receptor Antagonist Conjugated to Superparamagnetic Iron Oxide Nanoparticles for Theranostic Targeting of Experimental Glioblastoma

Por Maxim A. Shevtsov, Boris P. Nikolaev, Ludmila Y. Yakovleva, Anatolii V. Dobrodumov, Alexander V. Zhakhov, Anastasiy L. Mikhrina, Emil Pitkin, Marina A. Parr, Valerii I. Rolich, Andrei S. Simbircev, Alexander M. Ischenko
Publicado em 2015-01-01

Adherence to Antiemetic Guidelines in Patients with Malignant Glioma: A Quality Improvement Project to Translate Evidence into Practice

Por Affronti, Mary Lou, Schneider, Susan M., Herndon, James E., Schlundt, Susan, Friedman, Henry S.
Publicado no Support Care Cancer (2014)

TMOD-17. A NOVEL ADENOVIRAL-PERMISSIVE, IMMUNOCOMPETENT HAMSTER MODEL TO EVALUATE ONCOLYTIC ADENOVIRAL THERAPY FOR GLIOBLASTOMA

Por Phillips, Lynette, Li, Shoudong, Gumin, Joy, Ledbetter, Daniel, Hossain, Anwar, Kerrigan, Brittany, Gomez-Manzano, Candelaria, Fueyo, Juan, Lang, Frederick
Publicado no Neuro Oncol (2018)

AT-48 A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB...

Por Ranjan, Tulika, Peters, katherine B., Vlahovic, Gordana, Watts, Jason, Dutton, Shelley, Boulton, Susan, Lipp, Eric, Herndon, James, Healy, Patrick, Miller, Elizabeth, Friedman, Henry, Karmali, Rashida, Desjardins, Annick
Publicado em 2014

Aberrant CpG Islands Hypermethylation Profiles in Malignant Gliomas

Por Kim, Kwang Ryeol, Kim, Ealmaan, Son, Eun Ik
Publicado em 2014

Pediatric Low-Grade Gliomas

Por Sievert, Angela J., Fisher, Michael J.
Publicado em 2009

20-HETE-producing Enzymes Are Up-regulated in Human Cancers

Por ALEXANIAN, ANNA, MILLER, BRADLEY, ROMAN, RICHARD J., SOROKIN, ANDREY
Publicado em 2012